Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for sedation during ERCP
jRCTs051230088Recruiting
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of remimazolam in Hepatobiliary disorders and pancreatic diseases. Started Nov 2023; status: recruiting.
02
Drugs
remimazolam
03
Conditions
Hepatobiliary disorderspancreatic diseases
Beyond the preview
Go deeper on jRCTs051230088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051230088.